ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MRNS Marinus Pharmaceuticals Inc

1.41
0.01 (0.71%)
Last Updated: 09:03:58
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Marinus Pharmaceuticals Inc MRNS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.71% 1.41 09:03:58
Open Price Low Price High Price Close Price Previous Close
1.42 1.40 1.42 1.40
more quote information »

Recent News

Date Time Source Heading
4/15/202406:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
4/05/202415:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
3/27/202407:41BWMarinus Pharmaceuticals Comments on Patent Challenge by Ovid..
3/05/202415:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/202415:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
2/22/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202406:00BWMarinus Pharmaceuticals to Present at Upcoming Investor..
2/20/202406:00BWMarinus Pharmaceuticals to Provide Business Update and..
2/16/202415:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
2/14/202415:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202414:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202411:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202409:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202408:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202411:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/19/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
1/04/202406:04EDGAR2Form 8-K - Current report
1/04/202406:01BWMarinus Pharmaceuticals Reports Preliminary Fourth Quarter..
12/07/202315:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
11/28/202306:05EDGAR2Form 8-K - Current report
11/20/202315:01BWMarinus Pharmaceuticals Announces Seven Presentations at AES..
11/14/202315:05BWMarinus Pharmaceuticals to Present at the 6th Annual..
11/09/202315:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
11/07/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202306:11EDGAR2Form 8-K - Current report
11/07/202306:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
11/07/202306:00BWMarinus Pharmaceuticals Initiates Global Access Program for..
10/24/202306:01BWMarinus Pharmaceuticals to Provide Business Update and..
10/10/202315:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/06/202315:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
9/28/202306:05EDGAR2Form 8-K - Current report
9/21/202315:00BWMarinus Pharmaceuticals to Present at the 2023 Cantor Global..
9/19/202307:02EDGAR2Form 8-K - Current report
9/19/202307:00BWMarinus Pharmaceuticals Highlights Advancing Pipeline and..
9/12/202315:00BWMarinus Pharmaceuticals Announces Speakers for Hybrid..
9/06/202315:01BWMarinus Pharmaceuticals Announces Inducement Grants Under..

Your Recent History

Delayed Upgrade Clock